Clinical Trial Update: Everolimus in Refractory Testicular Germ Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Everolimus in refractory testicular germ cell tumor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Testicular Germ Cell Tumor

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: National Cancer Institute, Slovakia | Conditions: Germ Cell Tumor | Phase 2 | Status: COMPLETED